EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ensemble learning guided survival prediction and chemotherapy benefit analysis in high-grade chondrosarcoma: A study based on the surveillance, epidemiology, and end results (SEER) database

Xu Zheng, Longqiang Shu, Shanyi Lin, Hanqiang Jin, Xiaoyu Wang iD, Ting Yuan

Journal of Orthopaedic Surgery · 2025-05 · 33 (2)

DOI: 10.1177/10225536251340113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Surgery, online erschienen am 09.05.2025. Verfasst von Xu Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Chondrosarcoma, Bone Neoplasms, Machine Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The chemotherapy benefit for high-grade chondrosarcoma remains controversial. Ensemble learning has better overall performance than single computational approaches for clinical decision. The primary objective was to select prognostic variables and develop optimal ensemble learning algorithms for survival prediction and analyzing chemotherapy benefit in high-grade chondrosarcoma. The secondary objective included identifying specific patient groups with estimated survival benefit for guidance in chemotherapy strategies.

Methods

The data of 1931 patients with chondrosarcoma from 2000 to 2019 were obtained from the Surveillance, Epidemiology, and End Results database to conduct the retrospective analysis. Among 468 patients with high-grade chondrosarcoma, cox proportional hazards models and random survival forests were used for feature selection. Ensemble learning and survival support vector machine with different kernel methods were developed and compared for their prognostic performance.

Results

Ensemble learning outperformed the single models, with the concordance index reaching 0.764 (based on inverse probability of censoring weights) and the mean area under time-dependent receiver operating characteristic curve of 0.851. According to the ensemble model, overall survival generally improved in younger patients after chemotherapy. Age-stratified analysis revealed differential chemotherapy benefits across various clinical subgroups. Survival benefits were observed in: Age ≤ 10 with dedifferentiated chondrosarcoma, amputation, local surgical treatment, absence of distant metastasis, or grade III tumor; Age ≤ 20 who were male with clear cell chondrosarcoma, non-axial primary sites, or no radiotherapy; Age ≤ 30 who were female with primary site at pelvis/limb, received radiotherapy, extension beyond periosteum, further extension, or distant metastasis; Age≤40 with chondrosarcoma NOS (including mesenchymal, juxtacortical and classical chondrosarcoma); Age ≤ 50 with grade IV tumor or no surgery received.

Conclusion

Ensemble learning algorithms demonstrate outstanding overall performance in prognostic assessment of high-grade chondrosarcoma and identification of age-specific factors associated with chemotherapy benefit for tailored chemotherapy strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrosarcomaBone NeoplasmsMachine LearningHumansMaleFemaleMiddle AgedSEER ProgramRetrospective StudiesAdultAgedPrognosisYoung AdultAdolescentNeoplasm GradingSurvival RateChildEnsemble Learning

Stichwörter der Autor:innen

SEERchemotherapyensemble learninghigh-grade chondrosarcomamachine learningsurvival

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Xiaoyu Wang

Zitieren

APA

Zheng, X., Shu, L., Lin, S., Jin, H., Wang, X., & Yuan, T. (2025). Ensemble learning guided survival prediction and chemotherapy benefit analysis in high-grade chondrosarcoma: A study based on the surveillance, epidemiology, and end results (SEER) database. Journal of Orthopaedic Surgery, 33(2). https://doi.org/10.1177/10225536251340113

Vancouver

Zheng X, Shu L, Lin S, Jin H, Wang X, Yuan T. Ensemble learning guided survival prediction and chemotherapy benefit analysis in high-grade chondrosarcoma: A study based on the surveillance, epidemiology, and end results (SEER) database. Journal of Orthopaedic Surgery. 2025;33(2). doi:10.1177/10225536251340113

BibTeX
@article{Zheng2025,
  author = {Zheng, Xu and Shu, Longqiang and Lin, Shanyi and Jin, Hanqiang and Wang, Xiaoyu and Yuan, Ting},
  title = {Ensemble learning guided survival prediction and chemotherapy benefit analysis in high-grade chondrosarcoma: A study based on the surveillance, epidemiology, and end results (SEER) database},
  journal = {Journal of Orthopaedic Surgery},
  year = {2025},
  volume = {33},
  number = {2},
  doi = {10.1177/10225536251340113}
}
Kostenlos starten →